iShares Nasdaq Biotechnology ETF

Find Ratings Reports
IBB : NASDAQ : Financial
$289.79 -5.30 | -1.80%
Today's Range: 289.52 - 295.31
Avg. Daily Volume: 1,211,300
09/29/16 - 12:10 PM ET

PEER GROUP ANALYSIS

IBB Peer Plot Chart

This chart compares IBB to the highest rated funds in its peer group of Sector - Health/Biotechnology funds. The above graph illustrates two key measures that investors should consider when assessing the investment potential of a particular fund. One of the key factors is how the fund has performed over the most recent reporting period, defined as the 1 year total return on the bottom axis. The second factor is the fund's reported expense ratio, on the right axis, which includes things like management fees. The best funds, with higher returns and lower expenses, stake out a position in the lower left part of this graph.


TOP RATED FUNDS : Sector - Health/Biotechnology
NameTickerReturn
YTD
1 Year
Return
3 Year
Return
Expense
Ratio
Peer
Rank
iShares US Medical Devices ETF IHI 17.71 27.90 21.70 0.44 1
Health Care Select Sector SPDR XLV 1.63 7.91 14.98 0.15 2
Vanguard HealthCare Index ETF VHT 0.88 5.25 14.74 0.09 3
iShares US Healthcare ETF IYH 1.14 5.58 14.23 0.44 4
Gabelli Healthcare & WellnessRx Tr GRX 9.88 12.05 11.41 1.60 5
iShares Global Healthcare IXJ -0.44 4.00 11.82 0.47 6
iShares US Healthcare Providers ETF IHF -0.41 -4.67 12.42 0.44 7
BlackRock Health Sciences Trust BME -8.34 -3.61 14.41 1.12 8
ProShares Ultra Health Care RXL -0.46 6.06 25.43 0.95 9
iShares Nasdaq Biotechnology IBB -16.95 -16.64 11.79 0.47 19
The above table compares the total return performance and expense ratio of iShares Nasdaq Biotechnology to the top rated funds within the Sector - Health/Biotechnology peer group. iShares Nasdaq Biotechnology ranks number 19 out of 33 Sector - Health/Biotechnology closed-end and exchange-traded funds that we rate.

Latest Stock Upgrades/Downgrades